Effect of memantine on resting state default mode network activity in Alzheimer's disease (Q39791889)

14 September 2017

Effect of memantine on resting state default mode network activity in Alzheimer's disease (English)

1 reference

14 September 2017

0 references

12

1 reference

14 September 2017

Sandra Rosini

9

0 references

Marco Lorenzi

Marco Lorenzi

1

0 references

Francesca B. Pizzini

Francesca B Pizzini

6

0 references

Elisa Canu

Elisa Canu

4

0 references

Maria Cotelli

Maria Cotelli

8

0 references

Nicola B. Mercuri

Nicola B Mercuri

3

0 references

Carlo Caltagirone

11

Carlo Caltagirone

1 reference

14 September 2017

Alberto Beltramello

2

1 reference

14 September 2017

Giada Zoccatelli

5

1 reference

14 September 2017

Franco Alessandrini

7

1 reference

14 September 2017

Daniela Costardi

10

1 reference

14 September 2017

1 March 2011

1 reference

14 September 2017

1 reference

14 September 2017

28

1 reference

14 September 2017

205-217

1 reference

14 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.2165/11586440-000000000-00000

14 September 2017

0 references

cites work

Long-term effects of the concomitant use of memantine with cholinesterase inhibition in Alzheimer disease

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine treatment in mild to moderate Alzheimer disease: a 24-week randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine agonist action at dopamine D2High receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Dopamine transporter imaging in adult patients with attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Contraction of time in attention-deficit hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Visual hallucinations and agitation in Alzheimer's disease due to memantine: report of three cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

How default is the default mode of brain function? Further evidence from intrinsic BOLD signal fluctuations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Medial prefrontal cortex and self-referential mental activity: relation to a default mode of brain function

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Default-mode brain dysfunction in mental disorders: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Regional homogeneity, functional connectivity and imaging markers of Alzheimer's disease: a review of resting-state fMRI studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

The revised CONSORT statement for reporting randomized trials: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

The Clinical Dementia Rating (CDR): current version and scoring rules

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Pathological verification of ischemic score in differentiation of dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Claustrophobia and premature termination of magnetic resonance imaging examinations.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

A method for making group inferences from functional MRI data using independent component analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Performance of blind source separation algorithms for fMRI analysis using a group ICA method

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Age as risk factor for sporadic dementia of the Alzheimer type?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Mechanism of action of memantine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Localized in vivo 13C-NMR of glutamate metabolism in the human brain: initial results at 4 tesla.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

A coherent neurobiological framework for functional neuroimaging provided by a model integrating compartmentalized energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Cellular mechanisms of brain energy metabolism and their relevance to functional brain imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Reduced glutamate neurotransmission in patients with Alzheimer's disease -- an in vivo (13)C magnetic resonance spectroscopy study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

The inhibitory effects of beta-amyloid on glutamate and glucose uptakes by cultured astrocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Efficiency and cost of economical brain functional networks.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Decreased dopamine D4 receptor expression increases extracellular glutamate and alters its regulation in mouse striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Effects of NMDA receptor antagonists on D1 dopamine receptor-mediated changes in striatal immediate early gene expression: evidence for involvement of pharmacologically distinct NMDA receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine treatment reduces the expression of the K(+)/Cl(-) cotransporter KCC2 in the hippocampus and cerebral cortex, and attenuates behavioural responses mediated by GABA(A) receptor activation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Memantine protects rat cortical cultured neurons against beta-amyloid-induced toxicity by attenuating tau phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

The clinical use of structural MRI in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11586440-000000000-00000

Amphetamine and dopamine-induced immediate early gene expression in striatal neurons depends on postsynaptic NMDA receptors and calcium.

21 January 2018

1 reference

12 December 2020

beta-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus.

1 reference

12 December 2020

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

12 December 2020

Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide

1 reference

12 December 2020

Neurochemical changes in the cerebral cortex of treated and untreated hydrocephalic rat pups quantified with in vitro 1H-NMR spectroscopy.

1 reference

12 December 2020

Memantine treatment in patients with mild to moderate Alzheimer's disease: results of a randomised, double-blind, placebo-controlled 6-month study.

1 reference

12 December 2020

Memantine for dementia

1 reference

12 December 2020

Astrocytes Couple Synaptic Activity to Glucose Utilization in the Brain.

1 reference

12 December 2020

10.2165/11586440-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

14 September 2017

0 references

1 reference